...potential (see “Turning the Tide” ). Gottlieb thinks the public conversation over approval of Dsuvia sufentanil...

...episodes in Parkinson's disease patients treated with carbidopa-levodopa AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) FDA approves Dsuvia sufentanil...

...for the indication. AcelRx gained $0.65 (16%) to $4.80 Nov. 2 when FDA approved Dsuvia sufentanil...
...City, Calif. Pfizer Inc. (NYSE:PFE), New York, N.Y. Trevena Inc. (NASDAQ:TRVN), Chesterbrook, Pa. Product: Dsuvia sufentanil...

...Europe for the indication. AcelRx gained $0.65 (16%) to $4.80 Friday when FDA approved Dsuvia sufentanil...

...a new opioid analgesic, Commissioner Scott Gottlieb Friday explained the agency’s decision to approve Dsuvia sufentanil...

...Anesthetic and Analgesic Drug Products Advisory Committee voted 10-3 that the benefit-risk profile of Dsuvia sufentanil...
...letter from FDA in October 2017 for the candidate, which delivers a sublingual formulation of sufentanil...
...Dsuvia sufentanil sublingual tablet (ARX-04) Business: Neurology Elizabeth S. Eaton Dsuvia, Dzuveo, Sufentanil sublingual tablet (ARX-04, single-dose sufentanil...

...Anesthetic and Analgesic Drug Products Advisory Committee voted 10-3 that the benefit-risk profile of Dsuvia sufentanil...
...letter from FDA in October 2017 for the candidate, which delivers a sublingual formulation of sufentanil...
...$0.88 (22%) to $4.86 in after-hours trading. Elizabeth S. Eaton Dsuvia, Dzuveo, Sufentanil sublingual tablet (ARX-04, single-dose sufentanil...

...NYSE:ABBV) Upadacitinib (ABT-494) Rheumatoid arthritis Submit reg apps worldwide 4Q18 AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) Dsuvia sufentanil...

...will meet Oct. 12 to discuss an NDA from AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) for Dsuvia sufentanil...
...for Dsuvia (see “AcelRx’s Dsuvia Gets CRL” ). The product is a sublingual formulation of sufentanil...
...Dsuvia sufentanil sublingual tablet (ARX-04) Business: Neurology Jaime De Leon Dsuvia, Dzuveo, Sufentanil sublingual tablet (ARX-04, single-dose sufentanil...

...NASDAQ:CELG) Luspatercept (ACE-536) Beta-thalassemia Top-line Ph III BELIEVE data Mid-2018 AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) Dsuvia sufentanil...